|
US3891427A
(en)
*
|
1972-10-12 |
1975-06-24 |
Lectromelt Corp |
Method for melting prereduced ore and scrap
|
|
SE378735B
(fr)
*
|
1972-11-17 |
1975-09-08 |
Asea Ab |
|
|
US3939297A
(en)
*
|
1973-12-07 |
1976-02-17 |
Chase Brass & Copper Co., Incorporated |
Stoker feed system
|
|
SE7503782L
(sv)
*
|
1975-04-02 |
1976-10-03 |
Asea Ab |
Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
|
|
DE2632707C3
(de)
*
|
1976-07-21 |
1983-04-07 |
Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf |
Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
|
|
US4133967A
(en)
*
|
1977-06-24 |
1979-01-09 |
The United States Of America As Represented By The Secretary Of The Interior |
Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
|
|
US4447906A
(en)
*
|
1981-02-02 |
1984-05-08 |
Lectromelt Corporation |
Arc furnace for producing aluminum
|
|
SE8303372L
(sv)
*
|
1983-06-14 |
1984-12-15 |
Asea Ab |
Ugnsanordning for smeltning av metaller eller metallegeringar
|
|
AT384669B
(de)
*
|
1986-03-17 |
1987-12-28 |
Voest Alpine Ag |
Anlage zur herstellung von stahl aus schrott
|
|
CA1311787C
(fr)
*
|
1986-06-24 |
1992-12-22 |
Masahisa Tate |
Four electrique pour la fabrication d'acier, a soufflage par la sole
|
|
FR2705767B1
(fr)
*
|
1993-05-27 |
1995-07-21 |
Lorraine Laminage |
Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
|
|
DE4339226A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Mannesmann Ag |
Verfahren und Vorrichtung zur Wertstoffgewinnung
|
|
AT404841B
(de)
*
|
1995-04-10 |
1999-03-25 |
Voest Alpine Ind Anlagen |
Anlage und verfahren zum herstellen von eisenschmelzen
|
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
|
EP1181492B1
(fr)
*
|
1999-05-18 |
2005-08-03 |
Danieli Technology, Inc. |
Four a arc electrique et procede pour le chargement en continu
|
|
EP1702983A3
(fr)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Agents toxiques, ribozymes, ADNzymes et oligonucléotides antisens spécifiques des tissus et des pathogènes et procédé d'utilisation associé
|
|
AU2001278875B2
(en)
*
|
2000-07-06 |
2007-06-07 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tetrahydrobenzothiazole analogues as neuroprotective agents
|
|
AU2001276957A1
(en)
*
|
2000-07-17 |
2002-01-30 |
Advanced Research And Technology Institute |
Method of diagnosing pulmonary hypertension
|
|
JP5305553B2
(ja)
|
2000-10-12 |
2013-10-02 |
ユニバーシティー オブ ロチェスター |
癌細胞の増殖を阻害する組成物
|
|
US20040245317A1
(en)
*
|
2001-04-06 |
2004-12-09 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
|
|
AU2002341938B2
(en)
*
|
2001-10-01 |
2007-08-30 |
Vanderbilt University |
Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
|
|
WO2003029430A2
(fr)
*
|
2001-10-04 |
2003-04-10 |
The Government Of The United States Of America, As |
Sequences de marqueurs repetees en tandem
|
|
US7811992B2
(en)
|
2002-02-06 |
2010-10-12 |
Stasys Technologies, Inc. |
Anti-infarction molecules
|
|
DE60239566D1
(de)
|
2002-06-14 |
2011-05-05 |
Brigham And Women S Hospital Boston |
Verfahren zur behandlung und prävention von kolitis, an der il-13 und nk-t zellen beteiligt sind
|
|
AU2003257181A1
(en)
|
2002-08-05 |
2004-02-23 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
|
WO2004045520A2
(fr)
|
2002-11-15 |
2004-06-03 |
Musc Foundation For Research Development |
Modulateurs de complement cibles sur le recepteur 2 de complement
|
|
EP1624753B1
(fr)
|
2002-11-21 |
2012-01-25 |
The University of Utah Research Foundation |
Modulation purinergique d'odeur
|
|
EP1711517A4
(fr)
|
2004-01-21 |
2008-02-13 |
Univ Utah Res Found |
CANAL SODIQUE NAv1.7 MUTANT ET PROCEDES ASSOCIES
|
|
AU2005220874B2
(en)
|
2004-03-04 |
2010-12-23 |
Vanderbilt University |
Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
|
|
WO2006016904A2
(fr)
*
|
2004-04-14 |
2006-02-16 |
Uab Research Foundation |
Activateurs de la biosynthese de l'hexosamine en tant qu'inhibiteurs de lesion induite par l'ischemie ou le choc hemorragique
|
|
US20050244335A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Rinehart John J |
Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
|
|
WO2005110463A1
(fr)
|
2004-05-11 |
2005-11-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Procedes pour inhiber l'expression de cytokine pro-inflammatoire au moyen de ghreline
|
|
AU2005326817B2
(en)
|
2004-05-21 |
2012-04-19 |
Benaroya Research Institute |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
|
EP1811839A4
(fr)
*
|
2004-11-18 |
2008-08-06 |
Univ Rochester |
Procedes et compositions concernant l'esculentoside a
|
|
SG158153A1
(en)
|
2004-12-21 |
2010-01-29 |
Musc Found For Res Dev |
Compositions and methods for promoting wound healing and tissue regeneration
|
|
EP1877074B1
(fr)
|
2005-04-15 |
2013-03-27 |
The Government of the United States of America, as represented by the Secretary of Health and Human Services |
Traitement et prevention de la maladie intestinale inflammatoire agissant sur il-3 et sur les cellules nkt
|
|
ES2431315T3
(es)
|
2005-05-19 |
2013-11-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Epítopos funcionales del antígeno PsaA de Streptococcus pneumoniae y usos de los mismos
|
|
US8859585B2
(en)
*
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
ES2909600T3
(es)
|
2005-06-07 |
2022-05-09 |
Dsm Nutritional Products Ag |
Microorganismos eucarióticos para producir lípidos y antioxidantes
|
|
EP2402435A3
(fr)
|
2005-10-14 |
2012-03-28 |
MUSC Foundation For Research Development |
Ciblage du PAX2 pour l'induction de l'immunité à la tumeur à médiation DEFB1 et le traitement contre le cancer
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
EP1976985B1
(fr)
|
2005-12-29 |
2013-07-17 |
The Regents of the University of California Office of Technology Transfer |
Methodes et compositions associees au domaine kunitz mutant i de tfpi-2
|
|
EP2545933A3
(fr)
*
|
2006-01-05 |
2013-04-24 |
University Of Utah Research Foundation |
Procédés et compositions visant à améliorer les propriétés pharmacologiques ciblant le système nerveux
|
|
US8815804B2
(en)
*
|
2006-02-06 |
2014-08-26 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to targeting tumors and wounds
|
|
AU2007223427A1
(en)
*
|
2006-03-01 |
2007-09-13 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
EP1996732A4
(fr)
|
2006-03-02 |
2010-03-31 |
Uab Research Foundation |
Détection, traitement de maladies mycobactériennes et découverte de médicaments
|
|
AU2007272619B2
(en)
|
2006-07-10 |
2013-07-25 |
Synapsin Pharmaceuticals, Inc. |
Compositions and methods relating to Solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance
|
|
DK2049564T3
(en)
|
2006-08-02 |
2017-07-24 |
Uab Res Found |
METHODS AND COMPOSITIONS RELATED TO SOLUBLE MONOCLONAL VARIABLE Lymphocyte RECEPTORS WITH DEFINED ANTIGEN SPECIFICITY
|
|
EP2560001B1
(fr)
|
2006-09-21 |
2016-04-13 |
University of Rochester |
Compositions et procédés associés à une thérapie par glissement de protéines pour la dystrophie myotonique
|
|
WO2008136852A2
(fr)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Méthodes et compositions se rapportant à la structure et à la fonction de apobec3g
|
|
EP2104509A4
(fr)
|
2006-12-11 |
2010-03-24 |
Univ Utah Res Found |
Compositions et méthodes de traitement de l'angiogenèse pathologique et de la perméabilité vasculaire
|
|
US20120030779A1
(en)
|
2007-01-18 |
2012-02-02 |
University Of Utah Research Foundtion |
Compositions and methods for detecting, treating, or preventing reductive stress
|
|
CA2677665C
(fr)
|
2007-02-08 |
2019-11-05 |
University Of Utah Research Foundation |
Procedes et compositions apparentes a l'inhibition d'une entree virale
|
|
CN101801185A
(zh)
|
2007-03-22 |
2010-08-11 |
耶鲁大学 |
与控制可变剪接的核糖开关有关的方法和组合物
|
|
US8119693B2
(en)
|
2007-05-08 |
2012-02-21 |
Sanford-Burnham Medical Research Institute |
Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
|
|
WO2009023306A2
(fr)
|
2007-05-09 |
2009-02-19 |
Burnham Institute For Medical Research |
Ciblage de protéinases de l'hôte en tant que stratégie thérapeutique contre des pathogènes viraux et bactériens
|
|
US8329195B2
(en)
|
2007-05-23 |
2012-12-11 |
The Uab Research Foundation |
Detoxified pneumococcal neuraminidase and uses thereof
|
|
EP2426219A1
(fr)
|
2007-05-29 |
2012-03-07 |
Yale University |
Riborégulateurs (riboswitches) et procédés et compositions à utiliser avec les riborégulateurs
|
|
EP2166845B1
(fr)
|
2007-06-21 |
2015-10-21 |
Musc Foundation for Research Development |
Peptides c-terminaux d'alpha connexine (act) pour traiter la dégénérescence maculaire liée à l'âge
|
|
TW200916113A
(en)
|
2007-08-08 |
2009-04-16 |
Sod Conseils Rech Applic |
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
|
|
US20110081317A1
(en)
*
|
2007-08-08 |
2011-04-07 |
University Of Rochester |
Enhancing Gene Transfer
|
|
CA2696113A1
(fr)
*
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Activateurs de la phosphatase alcaline non specifique des tissus (tnap) et leurs utilisations
|
|
US8501912B2
(en)
|
2007-12-03 |
2013-08-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Filipil compositions and methods for treating cancer
|
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
|
EP2288922B1
(fr)
|
2008-05-08 |
2016-08-17 |
University of Utah Research Foundation |
Récepteurs sensoriels pour fatigue et douleur chroniques et leurs utilisations
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
AU2009281732A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20100286762A1
(en)
*
|
2009-03-18 |
2010-11-11 |
Musc Foundation For Research Development |
Compositions and Methods for Ameliorating Clinical Electrical Disturbances
|
|
US20120107331A1
(en)
|
2009-05-15 |
2012-05-03 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
|
WO2011020107A2
(fr)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions et méthodes de dépistage et de traitement du cancer du sein
|
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
US20110060000A1
(en)
|
2009-09-10 |
2011-03-10 |
Maurizio Grimaldi |
Acridine analogs in the treatment of gliomas
|
|
WO2011088076A2
(fr)
|
2010-01-12 |
2011-07-21 |
Yale University |
Motifs et composés arn structurés et leurs procédés d'utilisation
|
|
EP2544715A2
(fr)
|
2010-03-09 |
2013-01-16 |
Board Of Regents, University Of Texas System |
Procédés et compositions pour antigènes de chlamydia dans le diagnostic et le traitement d'infections et de maladies à chlamydia
|
|
EP2555802A1
(fr)
|
2010-04-08 |
2013-02-13 |
Sanford-Burnham Medical Research Institute |
Méthodes et compositions pour une administration améliorée de composés
|
|
WO2012021554A1
(fr)
|
2010-08-09 |
2012-02-16 |
Yale University |
Riborégulateurs, motifs et composés régulés par la di-gmp-ii cyclique, et procédés pour leur utilisation
|
|
JP2014501248A
(ja)
|
2010-12-15 |
2014-01-20 |
ニューロアジュヴァンツ，インコーポレイテッド |
ニューロペプチド類似体、組成物、及び疼痛の治療方法
|
|
KR20140026410A
(ko)
|
2011-03-15 |
2014-03-05 |
유니버시티 오브 유타 리서치 파운데이션 |
혈관 관련 황반병증 및 이의 증상을 진단 및 치료하는 방법
|
|
US20140323392A1
(en)
|
2011-03-28 |
2014-10-30 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
WO2013036636A1
(fr)
|
2011-09-06 |
2013-03-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions et procédés de traitement du cancer
|
|
WO2014008475A2
(fr)
|
2012-07-05 |
2014-01-09 |
The Ohio State University |
Compositions et procédés associés à des vaccins viraux
|
|
WO2014141111A1
(fr)
|
2013-03-14 |
2014-09-18 |
Pluristem Ltd. |
Méthode permettant de prévenir et de traiter la maladie du greffon contre l'hôte
|
|
WO2014201118A2
(fr)
|
2013-06-11 |
2014-12-18 |
Sanford-Burnham Medical Research Institute |
Compositions et méthodes de traitement ciblé de l'endométriose
|
|
LT3016512T
(lt)
|
2013-07-05 |
2020-03-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Tirpus cd33, skirtas mielodisplazinių sindromų (mds) gydymui
|
|
US9884895B2
(en)
|
2014-03-20 |
2018-02-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric coronavirus spike proteins
|
|
WO2016049380A1
(fr)
|
2014-09-24 |
2016-03-31 |
University Of Utah Research Foundation |
Mimétiques intermédiaires pré-épingle à cheveux du virus ebola et procédés d'utilisation
|
|
JP2018504141A
(ja)
|
2015-01-20 |
2018-02-15 |
アドキュア バイオテクノロジーズ、 エルエルシー |
非標的化アデノウイルス変異体および関連する方法
|
|
US10596247B2
(en)
|
2015-02-20 |
2020-03-24 |
Board Of Regents, The University Of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
|
US10765754B2
(en)
|
2015-08-28 |
2020-09-08 |
Navigen, Inc. |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
|
CA3010713A1
(fr)
|
2016-01-07 |
2017-07-13 |
Navigen, Inc. |
Inhibiteurs de peptide d de penetration du vih et leurs methodes d'utilisation
|
|
EP3430046A4
(fr)
|
2016-03-16 |
2019-10-23 |
Abeome Corporation |
Anticorps monoclonaux neutralisants dirigés contre l'il-25 et leurs utilisations
|
|
US10751340B2
(en)
|
2016-06-06 |
2020-08-25 |
University Of Central Florida Research Foundation, Inc. |
Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
|
|
JP2019523008A
(ja)
|
2016-07-29 |
2019-08-22 |
オハイオ ステート イノベーション ファウンデーション |
腫瘍溶解性ウイルスによるＰＴＥＮ−Ｌｏｎｇの発現
|
|
KR102650803B1
(ko)
|
2016-10-05 |
2024-03-25 |
유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 |
Nk 세포 및 항-pdl1 암 요법과 관련된 방법 및 조성물
|
|
WO2018176027A1
(fr)
|
2017-03-24 |
2018-09-27 |
Ohio State Innovation Foundation |
Nouveaux vecteurs viraux adéno-associés recombinés limitant la transduction hors cible dans le foie et leurs utilisations
|
|
AU2018243920B2
(en)
|
2017-03-28 |
2024-12-12 |
Mayo Foundation For Medical Education And Research |
Human PD1 peptide vaccines and uses thereof
|
|
WO2018196782A1
(fr)
|
2017-04-27 |
2018-11-01 |
The University Of Hong Kong |
Utilisation d'inhibiteurs de hcn pour le traitement du cancer
|
|
EP3630144A4
(fr)
|
2017-05-25 |
2021-03-31 |
University of Central Florida Research Foundation, Inc. |
Nouveaux virus oncolytiques pour sensibiliser des cellules tumorales à la destruction par des cellules tueuses naturelles
|
|
US20200225244A1
(en)
|
2017-09-26 |
2020-07-16 |
Sanford Burnham Prebys Medical Discovery Institute |
Compositions and methods for assessing painful demyelinating and nondemyelinating diseases
|
|
CN111479575B
(zh)
|
2017-12-13 |
2024-03-22 |
北卡罗莱纳州立大学 |
包含化疗剂和检查点抑制剂的组合物及使用方法
|
|
JP7551110B2
(ja)
|
2018-04-06 |
2024-09-17 |
ノース カロライナ ステート ユニバーシティ |
癌免疫療法のためのチェックポイント阻害剤の細胞集団を介した送達
|
|
EP3787655A4
(fr)
|
2018-05-07 |
2022-08-10 |
Georgia State University Research Foundation Inc. |
Compositions et procédés se rapportant à un extrait de rhamnus prinoides (gesho) pour l'inhibition de la formation de biofilm polymicrobien
|
|
US20210260187A1
(en)
|
2018-06-29 |
2021-08-26 |
North Carolina State University |
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
|
|
WO2020051507A1
(fr)
|
2018-09-06 |
2020-03-12 |
The Broad Institute, Inc. |
Ensembles d'acides nucléiques destinés à être utilisés dans une administration ciblée
|
|
US11331269B2
(en)
|
2018-09-06 |
2022-05-17 |
Massachusetts Institute Of Technology |
Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
|
|
WO2020092057A1
(fr)
|
2018-10-30 |
2020-05-07 |
Yale University |
Compositions et procédés de génération rapide et modulaire de lymphocytes t récepteurs d'antigènes chimériques
|
|
EP3873505A4
(fr)
|
2018-11-02 |
2022-08-10 |
The Johns Hopkins University |
Protéines tdp-43 chimériques adénovirales
|
|
WO2020161686A1
(fr)
|
2019-02-09 |
2020-08-13 |
King Abdullah University Of Science And Technology |
Compositions et méthodes diagnostiques et prognostiques du cancer
|
|
CN114364399A
(zh)
|
2019-06-21 |
2022-04-15 |
瓦西尼斯公司 |
脑信号蛋白-4d阻断剂(sema4d)与dc1疗法的联合疗法
|
|
AU2020315475A1
(en)
|
2019-07-18 |
2022-02-03 |
Direct Biologics Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
WO2021211760A1
(fr)
|
2020-04-14 |
2021-10-21 |
The Regents Of The University Of California |
Compositions de vaccin universel contre tous les coronavirus à séquence de grande taille
|
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
|
JP2023554589A
(ja)
|
2020-11-27 |
2023-12-28 |
ジェネラル ナノセラピューティクス エルエルシー |
免疫媒介性疾患の治療のための方法及び組成物
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
WO2023173137A1
(fr)
|
2022-03-11 |
2023-09-14 |
Yale University |
Compositions et méthodes de modification génétique efficace et stable de cellules eucaryotes
|
|
WO2023220644A1
(fr)
|
2022-05-10 |
2023-11-16 |
Yale University |
Compositions et méthodes à base de queues ctla-4 synthétiques pour la reprogrammation de lymphocytes car-t et l'amélioration de l'efficacité anti-tumorale
|
|
KR102751454B1
(ko)
*
|
2022-06-03 |
2025-01-10 |
현대제철 주식회사 |
전기로
|
|
KR102736561B1
(ko)
*
|
2022-06-03 |
2024-12-02 |
현대제철 주식회사 |
전기로
|
|
KR102752443B1
(ko)
*
|
2022-08-26 |
2025-01-09 |
현대제철 주식회사 |
전기로
|
|
WO2024064824A2
(fr)
|
2022-09-21 |
2024-03-28 |
Yale University |
Compositions et procédés d'identification de cibles membranaires pour l'amélioration d'une thérapie par cellules nk
|
|
WO2024102997A1
(fr)
|
2022-11-11 |
2024-05-16 |
Peterson Jeff R |
Procédés de prévention de poussée de goutte à l'aide d'inhibiteurs d'il-1 bêta
|
|
WO2024155821A1
(fr)
|
2023-01-18 |
2024-07-25 |
Yale University |
Récepteurs antigéniques chimériques (car) ayant des régions intrinsèquement désordonnées et leurs méthodes d'utilisation
|
|
WO2024226829A2
(fr)
|
2023-04-26 |
2024-10-31 |
Yale University |
Molécules de liaison à enpp3, compositions formées à partir de celles-ci, et leurs procédés d'utilisation pour le traitement du cancer
|
|
WO2024238656A1
(fr)
|
2023-05-15 |
2024-11-21 |
Yale Univeristy |
Compositions de récepteurs antigéniques chimériques, cellules car-mast ainsi formées et procédés d'utilisation associés
|